Clinical Translation of Combined MAPK and Autophagy Inhibition in <i>RAS</i> Mutant Cancer

<i>RAS</i> (rat sarcoma virus) mutant cancers remain difficult to treat despite the advances in targeted therapy and immunotherapy. Targeted therapies against the components of mitogen-activated protein kinase (MAPK) pathways, including <i>RAS</i>, RAF, MEK, and ERK, have dem...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jennifer J. Lee, Vaibhav Jain, Ravi K. Amaravadi
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/24c45a2ea6b847d1986090179b718cf8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!